190 related articles for article (PubMed ID: 30684574)
1. Lipophilic 5-fluorouracil prodrug encapsulated xylan-stearic acid conjugates nanoparticles for colon cancer therapy.
Sauraj ; Kumar V; Kumar B; Deeba F; Bano S; Kulshreshtha A; Gopinath P; Negi YS
Int J Biol Macromol; 2019 May; 128():204-213. PubMed ID: 30684574
[TBL] [Abstract][Full Text] [Related]
2. Redox responsive xylan-SS-curcumin prodrug nanoparticles for dual drug delivery in cancer therapy.
Sauraj ; Vinay Kumar ; Kumar B; Priyadarshi R; Deeba F; Kulshreshtha A; Kumar A; Agrawal G; Gopinath P; Negi YS
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110356. PubMed ID: 31761247
[TBL] [Abstract][Full Text] [Related]
3. pH-responsive prodrug nanoparticles based on xylan-curcumin conjugate for the efficient delivery of curcumin in cancer therapy.
Sauraj ; Kumar SU; Kumar V; Priyadarshi R; Gopinath P; Negi YS
Carbohydr Polym; 2018 May; 188():252-259. PubMed ID: 29525163
[TBL] [Abstract][Full Text] [Related]
4. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
[TBL] [Abstract][Full Text] [Related]
5. Redox-sensitive nanoparticles based on xylan-lipoic acid conjugate for tumor targeted drug delivery of niclosamide in cancer therapy.
Sauraj ; Kumar A; Kumar B; Kulshreshtha A; Negi YS
Carbohydr Res; 2021 Jan; 499():108222. PubMed ID: 33401229
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and bio-evaluation of xylan-5-fluorouracil-1-acetic acid conjugates as prodrugs for colon cancer treatment.
Sauraj ; Kumar SU; Gopinath P; Negi YS
Carbohydr Polym; 2017 Feb; 157():1442-1450. PubMed ID: 27987854
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of 5-fluorouracil and shikonin by blended and coated chitosan/pectin nanoparticles for treatment of colon cancer.
Daneshmehr M; Pazhang M; Mollaei S; Ebadi M; Pazhang Y
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132413. PubMed ID: 38761911
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid embedded cellulose acetate phthlate core/shell nanoparticulate carrier of 5-fluorouracil.
Garg A; Rai G; Lodhi S; Jain AP; Yadav AK
Int J Biol Macromol; 2016 Jun; 87():449-59. PubMed ID: 26955748
[TBL] [Abstract][Full Text] [Related]
9. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin.
Guo H; Zhang D; Li C; Jia L; Liu G; Hao L; Zheng D; Shen J; Li T; Guo Y; Zhang Q
Int J Pharm; 2013 Dec; 458(1):31-8. PubMed ID: 24140544
[TBL] [Abstract][Full Text] [Related]
11. pH-responsive stearic acid-O-carboxymethyl chitosan assemblies as carriers delivering small molecular drug for chemotherapy.
Luo F; Fan Z; Yin W; Yang L; Li T; Zhong L; Li Y; Wang S; Yan J; Hou Z; Zhang Q
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110107. PubMed ID: 31546448
[TBL] [Abstract][Full Text] [Related]
12. Encapsulation and Systemic Delivery of 5-Fluorouracil Conjugated with Silkworm Pupa Derived Protein Nanoparticles for Experimental Lymphoma Cancer.
Reneeta NP; Thiyonila B; Aathmanathan VS; Ramya T; Chandrasekar P; Subramanian N; Prajapati VK; Krishnan M
Bioconjug Chem; 2018 Sep; 29(9):2994-3009. PubMed ID: 30089206
[TBL] [Abstract][Full Text] [Related]
13. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
[TBL] [Abstract][Full Text] [Related]
14. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy.
Qu CY; Zhou M; Chen YW; Chen MM; Shen F; Xu LM
Int J Nanomedicine; 2015; 10():3911-20. PubMed ID: 26089667
[TBL] [Abstract][Full Text] [Related]
15. Dibutyrylchitin nanoparticles as novel drug carrier.
Jain T; Kumar S; Dutta PK
Int J Biol Macromol; 2016 Jan; 82():1011-7. PubMed ID: 26592700
[TBL] [Abstract][Full Text] [Related]
16. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
17. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
Varshosaz J; Hassanzadeh F; Sadeghi H; Khadem M
J Liposome Res; 2012 Sep; 22(3):224-36. PubMed ID: 22385296
[TBL] [Abstract][Full Text] [Related]
18. Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment.
Jin Y; Yang F; Du L
Colloids Surf B Biointerfaces; 2013 Dec; 112():421-8. PubMed ID: 24036626
[TBL] [Abstract][Full Text] [Related]
19. Preparation and Bioactivity Assessment of Chitosan-1-Acetic Acid-5-Flurouracil Conjugates as Cancer Prodrugs.
Mohammed MO; Hussain KS; Haj NQ
Molecules; 2017 Nov; 22(11):. PubMed ID: 29117097
[TBL] [Abstract][Full Text] [Related]
20. Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI.
Cheng Z; Dai Y; Kang X; Li C; Huang S; Lian H; Hou Z; Ma P; Lin J
Biomaterials; 2014 Aug; 35(24):6359-68. PubMed ID: 24816364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
